Article
Integrative analysis of somatic mutations and transcriptomic data to functionally stratify breast cancer patients.
BMC genomics - 22 Aug 2016
Zhang Jie, Abrams Zachary, Parvin Jeffrey D, Huang Kun
Abstract excerpt
BACKGROUND: Somatic mutations can be used as potential biomarkers for subtyping and predicting outcomes for cancer patients. However, cancer patients often carry many somatic mutations, which do not always concentrate on specific genomic loci, suggesting that the mutations may affect common pathways or gene interaction networks instead of common genes. The challenge is thus to identify the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
